Understanding the inflammatory cycle is key to understanding why so many modern health concerns persist. Increasing evidence now points to molecular hydrogen as a potential tool for moderating this cycle and supporting overall cellular health.
A new study led by researchers at University College London (UCL) suggests that routine blood tests could significantly enhance early cancer diagnosis for individuals experiencing stomach pain or bloating.
Among the excitement of summer, it’s crucial to stay informed about how the season can affect our health, particularly when it comes to medications and medical devices.
Researchers from UCL and Moorfields Eye Hospital have identified potential markers in the blood that could change the treatment of glaucoma, a leading cause of irreversible blindness worldwide.
New research highlights a crucial consideration for men battling prostate cancer, a potentially heightened risk of heart disease when certain medications are combined.
Associate Professor Ailsa McGregor from the University of Otago's School of Pharmacy has set on a mission to enhance the efficacy and safety of lithium treatment for patients battling bipolar disorder (BD).
A recent multicenter randomised clinical trial has cast doubt on the efficacy of vaginal micronised progesterone (VMP) in preventing preterm birth in women with arrested preterm labour (APTL).
Researchers at the University of Notre Dame have a development in cancer therapy: a miniature, wireless LED device that can be implanted directly into deep-seated tumours.
The NHS Business Services Authority (NHSBSA) has disclosed its annual report detailing the prescription trends for mental health medications in England, covering the financial...
In a new effort to revolutionise treatment for eye injuries and disorders, a team of researchers from the University of Liverpool have secured £2.1 million in funding.
A recent advisory panel to the Food and Drug Administration (FDA) has cast significant doubt on the potential approval of MDMA-assisted therapy for post-traumatic stress disorder (PTSD).
In June, Alzheimer's and brain awareness month, Mayo Clinic researchers have identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease.
Imagine a world where children's medicine tastes like chocolate, seniors can take just one pill for all their daily medications, and you can get a drug made specifically for your unique health needs right at your local pharmacy.
